← Eichor
Condition: Tumor Thrombus Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Tumor Thrombus

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Phase II Study of Moderate-dose Hypofractionated RT Combined With Pembrolizumab for HCC With Diffuse Tumor Thrombosis
Phase 2 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT06389422Immune Checkpoint Inhibitor Associated Cardiovascular Adverse Events in Patients With Cancer
Phase N/A · 1 location(s) · Hanneke W. M. van Laarhoven · NCT06519292Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism
NA · 8 location(s) · Memorial Sloan Kettering Cancer Center · NCT07399977Multi-modal Quantitative Imaging of the Skin
Phase N/A · 3 location(s) · HJN Sverige AB/Neko Health · NCT06989216Blood Viscosity in Polycythemia Patients
Phase N/A · 1 location(s) · Hospices Civils de Lyon · NCT06421025Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus
Phase 2 · 3 location(s) · University of Colorado, Denver · NCT05969496Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC
Phase 4 · 1 location(s) · Mansoura University · NCT07132515A Study of Cardiac Magnetic Resonance Imaging (CMR) for Evaluating Catheter-Associated Right Atrial Clot in People With
NA · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07549477Determination of the Clonality Profile in Myeloproliferative Neoplasms and Association With the Thrombotic Complications
Phase N/A · 11 location(s) · University Hospital, Bordeaux · NCT05839717Venous Thromboembolism Prevention in Outpatients With Glioma
Phase 2 · 1 location(s) · University of Vermont Medical Center · NCT05683808Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU
NA · 1 location(s) · Brigham and Women's Hospital · NCT06538376Prognostic Value of NETosis Markers for Thrombosis During Myeloproliferative Neoplasms (AVATARE)
NA · 15 location(s) · University Hospital, Bordeaux · NCT07119970Conversion Therapy With FOLFOX-HAIC Plus Lenvatinib And Tislelizumab For Hepatocellular Carcinoma With Vp3 Portal Vein T
Phase 2 · 1 location(s) · First Hospital of China Medical University · NCT07483359Development of a Risk Stratification Score for Recurrent Venous Thromboembolism and Treatment-related Clinically Relevan
Phase N/A · 1 location(s) · Ottawa Hospital Research Institute · NCT06894576Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery
Phase N/A · 1 location(s) · The First Hospital of Jilin University · NCT07439991VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy
Phase 2/Phase 3 · 1 location(s) · Ottawa Hospital Research Institute · NCT05920343Positron Emission Tomography (PET) Imaging of Thrombosis
Phase 1 · 1 location(s) · Massachusetts General Hospital · NCT03830320Neoadjuvant Lenvatinib and Pembrolizumab for IVC Tumor Thrombus
Phase 2 · 1 location(s) · University of Texas Southwestern Medical Center · NCT05319015TIPS Combined With Lenvatinib and PD-1 Inhibitor for Advanced HCC With Main Trunk PVTT
NA · 1 location(s) · Sun Yat-sen University · NCT06622031Pre- Vs. Postoperative Thromboprophylaxis in Pancreatic Surgery
Phase 4 · 5 location(s) · Helsinki University Central Hospital · NCT05245877Secondary Prevention of VTE in Patients With Cancer and Catheter-Related Upper Extremity Deep Vein Thrombosis
Phase 4 · 1 location(s) · Ottawa Hospital Research Institute · NCT06603870Thrombin Generation Parameters and Bleeding in Patients Treated With Anticoagulants for Cancer Associated Thrombosis
NA · 4 location(s) · Centre Hospitalier Universitaire de Saint Etienne · NCT06386107External Validation of the CLOVER Score for Detecting Occult Cancer in Venous Thromboembolism Patients
Phase N/A · 12 location(s) · Infanta Leonor University Hospital · NCT07310693The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And
Phase 3 · 1 location(s) · Sun Yat-sen University · NCT03368651Radioembolization as a Spearhead Treatment of Hepatocellular Carcinoma With Localized Portal Vein Tumor Thrombosis
Phase 2 · 4 location(s) · Seoul National University Hospital · NCT06166576Ultra Low Dose CT and Use of Iomeron 400 in PCD-CT
NA · 1 location(s) · University of Zurich · NCT06360627Intraoperative Paravertebral Block and Postoperative Complications
NA · 1 location(s) · Tongji Hospital · NCT07211529Registry of Thrombosis & NEoplasia of "Sociedad Española de Oncología Médica"
Phase N/A · 48 location(s) · Fundación Sociedad Española de Oncologia Médica · NCT03855592DOAC - Dosing Options in AntiCoagulation Prophylaxis
Phase 3 · 1 location(s) · University of Vermont · NCT07005024Evaluation of the Pathobiology of CALR-mutated MPN Cells
Phase N/A · 2 location(s) · Wake Forest University Health Sciences · NCT06480591
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.